Serotype distribution and drug resistance in Streptococcus pneumoniae, palestinian territories

Emerging Infectious Diseases

Volumn 17, Issue 1, 2011, Pages 94-96

  Kattan, Randa ^a,b   Abu Rayyan, Amal ^b   Zheiman, Inas ^c   Idkeidek, Suzan ^c   Baraghithi, Sabri ^c   Rishmawi, Nabeel ^a   Turkuman, Sultan ^a   Abu Diab, Afaf ^a   Ghneim, Riyad ^a   Zoughbi, Madeleine ^a   Dauodi, Rula ^a   Ghneim, Raed ^a   Issa, Abed El Razeq ^a   Siryani, Issa ^a   Al Qas, Randa ^a   Liddawi, Rawan ^a   Khamash, Hatem ^c   Kanaan, Moein ^b   Marzouqa, Hiyam ^a   Hindiyeh, Musa Y ^a,b  

^a Caritas Baby Hospital

^b BETHLEHEM UNIVERSITY   (Palestine)

^c Maqassed Islamic Hospital

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; COTRIMOXAZOLE; ERYTHROMYCIN; OFLOXACIN; OXACILLIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; CHILD; ENDOCARDITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PALESTINE; PRESCHOOL CHILD; SCHOOL CHILD; SEPSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE EAST; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 78650987034     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1701.100886     Document Type: Article

References (14)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893-902. DOI: 10.1016/S0140-6736(09)61204-6
2. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008;6:288-301. DOI: 10.1038/nrmicro1871
3. Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Doern GV. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus infl uenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents. 2005;25:148-156. DOI: 10.1016/j.ijantimicag.2004.09.016
4. Ispahani P, Slack RC, Donald FE, Weston VC, Rutter N. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Arch Dis Child. 2004;89:757-762. DOI: 10.1136/adc.2003.036921
5. Saha SK, Baqui AH, Darmstadt GL, Ruhulamin M, Hanif M, El Arifeen S, et al. Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol. 2003;41:5582-5587. DOI: 10.1128/JCM.41.12.5582-5587.2003
6. Centers for Disease Control and Prevention. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine-United States, 2007. MMWR Morb Mortal Wkly Rep. 2010;59:253-257.
7. Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis. 2008;47:1388-1395. DOI: 10.1086/592972
8. Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44:124-131. DOI: 10.1128/JCM.44.1.124-131.2006
9. Fraser D, Givon-Lavi N, Bilenko N, Dagan R. A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice. Clin Infect Dis. 2001;33:421-427. DOI: 10.1086/321874
10. Mokaddas EM, Rotimi VO, Albert MJ. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin Vaccine Immunol. 2008;15:203-207. DOI: 10.1128/CVI.00277-07
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 29th infomational supplement; CLSI document M100-S19. Wayne (PA): The Institute; 2009.
12. Imohl M, Reinert RR, van der Linden M. Serotype-specifi c penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008. Int J Med Microbiol. 2010;300:324-330. DOI: 10.1016/j.ijmm.2009.11.004
13. Centers for Disease Control and Prevention. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae-United States, 2006-2007. MMWR Morb Mortal Wkly Rep. 2008;57:1353-1355.
14. Rowe AK, Schwartz B, Wasas A, Klugman KP. Evaluation of the Etest as a means of determining the antibiotic susceptibilities of isolates of Streptococcus pneumoniae and Haemophilus infl uenzae from children in the Central African Republic. J Antimicrob Chemother. 2000;45:132-133. DOI: 10.1093/jac/45.1.132